Here are 13 key notes on major spine and orthopedic device companies.
Alphatec Spine appointed James M. Corbett as president and CEO, and eliminated the Senior Vice President, U.S. Commercial Operations position. The company's director Luke Faulstick will also step down.
Danaher appointed Thomas Joyce, Jr. as president and CEO.
Expanding Orthopedics' FLXfit — a 3D expandable intervertebral TLIF cage — will be presented at the International Society for the Advancement of Spine Surgery Annual Meeting.
Integra LifeSciences appointed Glenn G. Coleman corporate vice president and CFO, effective May 2.
InVivo Therapeutics began shipment of its investigational device, the Neuro-Spinal Scaffold for spinal cord injury patients, for initiation of its first clinical trial.
NuVasive reported a net loss of $18.3 million in the first quarter of 2014, down from the same period last year when the company earned a net income of $851,000. The company's CFO Michael Lambert announced plans to retire on effective July 31.
Orthofix appointed James F. Hinrichs to its board of directors, effective immediately.
Osiris Therapeutics named Dwayne Montgomery general manager, orthopedics and sports medicine.
RTI Surgical announced a net loss of $3.1 million in the first quarter of 2014, up from the same period last year, when its net loss was $1.5 million.
SI-BONE completed a $33 million growth capital round of financing.
Smith & Nephew will premier a surgical webcast featuring the Smith & Nephew JOURNEY II Cruciate Retaining Knee System.
Zimmer and Biomet's respective boards of directors have approved a definitive agreement, under which Zimmer will acquire Biomet in a transaction valued at approximately $13.35 billion.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws